Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study, Schizophrenia Research, vol.52, issue.1-2, pp.29-36, 2001. ,
, American Psychiatric Association. DSM-IV-R. Manuel diagnostic et statistique des troubles mentaux, Masson, 2003.
Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia ,
, Schizophrenia Research, vol.54, issue.3, pp.223-230, 2002.
Symptoms, signs, and diagnosis of schizophrenia, Lancet, 1995. ,
Negative v positive schizophrenia. Définition and validation, Archives of general Psychiatry, vol.39, issue.7, pp.789-794, 1982. ,
DOI : 10.1001/archpsyc.1982.04290070025006
Self-experienced vulnerability, prodromal symptoms and coping strategies preceding schizophrenic and depressive relapses, European Psychiatry, vol.17, issue.7, pp.384-393, 2002. ,
DOI : 10.1016/s0924-9338(02)00698-3
,
Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment, British Journal of Psychiatry, vol.187, pp.45-48, 2005. ,
,
,
,
, L'initiation thérapeutique dans les épisodes psychotiques et maniaques: recueil des attitudes françaises par Focus Group. L'Encéphale, vol.38, 2012.
Reality monitoring and psychotic hallucinations ,
, British Journal of Clinical Psychology, vol.30, pp.213-222, 1991.
Glutathione: a novel treatment target in psychiatry, Trends in Pharmacological Sciences, issue.7, pp.346-351, 2008. ,
The perception of selfproduced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring, Psychological Medicine, vol.30, issue.5, pp.1131-1139, 2000. ,
,
, Dementia Praecox ou groupe de schizophrénies, Epel Editions, 2012.
Schizophrénie et réadaptation. Interventions spécifiques selon les phases de la maladie. Formation Continue, Annales Médicopsychologiques, vol.164, pp.869-876, 2006. ,
,
Duration of untreated psychosis and negative symptoms. A systematic review and meta-analysis of individual patients data, Schizophrenia Research, 2012. ,
Increase in schizophrenia incidence rates: findings in canadian cohort born 1975-1985, Social Psychiatry ans Psychiatric Epidemiology, issue.8, pp.611-618, 2006. ,
A disturbance of nonlinear interdependence in scalp EEG of subjects with first episode schizophrenia, NeuroImage, vol.20, issue.1, pp.466-478, 2003. ,
,
, Source monitoring deficits in hallucinating compared to non-hallucinating patients with schizophrenia, European Psychiatry, vol.21, pp.259-261, 2006.
Un déficit de la mémoire de source spécifique chez les patients schizophrènes comparés à des volontaires sains et des patients présentant un épisode dépressif majeur, 2008. ,
The schizophrenia high-risk project in Copenhagen: three decades of progress, Acta Psychiatrica Scandinavica, vol.370, pp.33-47, 1993. ,
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis, Schizophrenia Bulletin, 2012. ,
EASE: Évaluation des Anomalies de l ,
, , vol.38, pp.121-145, 2012.
EASE : Examination of Anomalous Self-experience), 2005. ,
,
,
Introduction à la psychopathologie phénoménologie, Paris MJW Edition, p.230, 2010. ,
Psychiatrie phénoménologique et existentielle, Elsevier Masson Psychiatrie, vol.11, pp.1-13, 2014. ,
,
Anomalous selfexperiences and their relationship with symptoms, neuro-cognition, and functioning in at-risk adolescents and young adults, Comprehensive Psychiatry, vol.65, pp.44-49, 2016. ,
Prodromal interventions for schizophrenia vulnerability: the risk of being « at risk », Schizophrenia Research, p.73, 2005. ,
Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents, The Journal of Clinical Psychiatry, vol.68, issue.4, pp.546-557 ,
Corollary discharge across the animal kingdom, Nature Reviews Neuroscience, 2008. ,
Positive and negative schizophrenic symptoms and the role of dopamine ,
, The British Journal of Psychiatry: The Journal of Mental Science, vol.137, 1980.
A randomised controlled trial of prophylactic neuroleptic treatment, The British Journal of Psychiatry: The Journal of Mental Science, vol.148, pp.120-127, 1986. ,
,
, Beyond the critical period: longitudinal study of 8-year outcome in first-episode nonaffective psychosis, The British Journal of Psychiatry: The Journal of Mental Science, vol.194, issue.1, pp.18-24, 2009.
Investigating in the biology of consciousness, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.353, pp.1879-1882, 1998. ,
Approches cliniques et diagnostiques des premiers épisodes psychotiques. Formation continue, Annales MédicoPsychologiques, vol.167, pp.79-85, 2009. ,
DOI : 10.1016/j.amp.2008.11.014
Les antipsychotiques lors d'un premier épisode psychotique. Formation continue, Annales Médico-Psychologiques, vol.167, pp.86-92, 2009. ,
DOI : 10.1016/j.amp.2008.11.015
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 ans 11, Clinical Research Ed, 1994. ,
,
Environmental factors ans social adjustment as predictors of a first psychosis in subjects at ultra-high risk, Schizophrenia Research, vol.125, issue.1, 2011. ,
Prolonged recovery in first-episode psychosis, The British Journal of Psychiatry, Supplement, p.172, 1998. ,
Prodromal symptoms of schizophrenia, L'Encephale, vol.29, issue.6, pp.469-477, 2003. ,
Safety of the omega-3 fatty acid, eicosapentanoenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial, Psychiatry Research, vol.161, pp.284-291, 2008. ,
The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up, Archives of General Psychiatry, vol.52, issue.10, 1995. ,
Avec le soutien de la Direction Générale de la Santé, Schizophrénie débutantes: diagnostic et modalités thérapeutiques. Conférence de consensus, 2003. ,
Efference copy and corollary discharge: implications for thinking and its disorders, Schizophrenia Bulletin, vol.4, issue.4, pp.636-640, 1978. ,
, La schizophrénie dans, p.5
, Annales Médico-psychologiques, 2015.
Six-month stability of psychiatric diagnoses in first-admission patient with psychosis, American Journal of Psychiatry, vol.151, pp.1200-1208, 1994. ,
Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as independent syndrome in medical nomenclature, Schizophrenia Bulletin, vol.36, issue.2, pp.314-320, 2010. ,
Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia, Journal of Neuroscience, vol.16, issue.21, pp.7055-7062, 1996. ,
Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging, Archives of General Psychiatry, vol.55, issue.11, pp.1001-1008, 1998. ,
Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia, Nature Reviews Neuroscience, vol.10, issue.1, 2009. ,
,
, Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis, The British Journal of Psychiatry: The Journal of Mental Science, vol.158, pp.171-176, 1991.
Reduced communication between frontal and temporal lobes during talking in schizophrenia, Biological Psychiatry, issue.6, pp.485-492, 2002. ,
Reduced gammaband coherence to distorted feedback during speech when what you say is not what you hear, International Journal of Psychophysiology, vol.57, issue.2, pp.143-150, 2005. ,
Dissecting corollary discharge dysfunction in schizophrenia, Psychophysiology, vol.44, issue.4, pp.522-529, 2007. ,
Out-of-synch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia, Biological Psychiatry, vol.63, issue.8, 2008. ,
Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their non psychotic first-degree relatives, Schizophrenia Bulletin, 2012. ,
Cognitive behavior therapy for psychosis: theory and practice, 1995. ,
Approche neurocognitive de la schizophrénie, et Rouillon F, pp.269-277, 2012. ,
,
, Confusion between silent and overt reading in schizophrenia, Schizophrenia Research, vol.41, pp.357-364, 2000.
The role of the therapeutic alliance in the treatment of schizophrenia. Relationship with course and outcome, Archives of General Psychiatry, vol.47, pp.228-236, 1990. ,
Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action, Psychological Medicine, vol.19, pp.359-363, 1989. ,
The cognitive neuropsychology of schizophrenia. Lawrence Erlbaum, 1992. ,
Explaining the symptoms of schizophrenia: abnormalities in the awareness of action, Brain Research Review, vol.31, issue.2-3, 2000. ,
Explaining deletion of control: the comparator model 20 years on, Consciousness and Cognition, vol.21, issue.1, pp.52-54, 2012. ,
Can antidepressants prevent psychosis?, Lancet, vol.370, issue.9601, pp.1746-1748, 2007. ,
,
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk, Archives of General Psychiatry, vol.69, 2012. ,
The psychosis high-risk state: a comprehensive state-ofthe-art review, JAMA Psychiatry, vol.70, issue.1, pp.107-120, 2013. ,
Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra-high risk, Schizophrenia Bulletin, vol.40, issue.1, pp.120-131, 2014. ,
,
antipsychotic and psychological interventions in subjects at high clinical risk of psychosis: OASIS 6years naturalistic study, Psychological Medicine, vol.45, pp.1327-1339, 2015. ,
Philosophical conceptions of the self: implications for cognitive science, Trends in Cognitive Sciences, 2000. ,
Impaired action selfmonitoring and cognitive confidence among ultra-high risk for psychosis and firstepisode psychosis patients, European Psychiatry, 2017. ,
,
Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first-episode schizophrenia, Schizophrenia Research, vol.107, issue.2-3, pp.262-266, 2009. ,
Integrating schizophrenia, Schizophrenia Bulletin, vol.24, issue.2, pp.249-266, 1998. ,
Psychopathology of basic stages of schizophrenia in view of formal thought disturbances, Psychopathology, vol.18, issue.2-3, pp.115-125, 1985. ,
The « basic » symptoms of schizophrenia, The British Journal of Psychiatry, Supplement, vol.7, pp.21-25, 1989. ,
Antipsychotic drugs and extrapyramidal side effects in first-episode psychosis: a systematic review of head-head comparaison, Journal of Psychopharmacology, vol.26, 2012. ,
Onset and early course as determinants of the further course of schizophrenia, Acta Psychiatrique Scandinavica, vol.102, issue.407, pp.44-48, 2000. ,
First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences, European Archives of Psychiatry and Clinical Neurosciences, vol.242, pp.109-118, 1992. ,
Epidemiology of schizophrenia, Canadian Journal of Psychiatry, vol.42, pp.139-151, 1997. ,
The ABC schizophrenia study: a preliminary overview of the results, Social Psychiatry and Psychiatric Epidemiology, issue.8, pp.380-386, 1998. ,
Early detection and secondary prevention of psychosis: facts and visions ,
, European Archives of Psychiatry and Clinical Neurosciences, vol.254, issue.2, pp.117-128, 2004.
Substance abuse and the onset of schizophrenia, Biological Psychiatry, vol.40, issue.11, pp.1155-1163, 1996. ,
Clinical characteristics of 50 first-admitted ICD-10 schizotypal patients, Br J Psychiatry Suppl, vol.48, pp.49-54, 2005. ,
Reality monitoring in mania and schizophrenia, The Journal of Nervous and Mental Disease, vol.173, pp.67-73, 1985. ,
,
, The association between self-disorders and neurocognitive dysfunction in schizophrenia, Schizophrenia Research, vol.135, pp.79-83, 2012.
,
, Selective aggregation of self-disorders in first-treatment DSM-IV schizophrenia spectrum disorders, The Journal of Nervous and Mental Disease, 2012.
Anomalous self-experiences contribute independently to social dysfunction in the early phases of schizophrenia and psychotic bipolar disorder, Comprehensive Psychiatry, vol.55, pp.475-482, 2014. ,
High levels of anomalous self-experience are associated with longer duration of untreated psychosis. Early Intervention in Psychiatry, 2015. ,
, Haute Autorité de Santé, ALD n° 23 Guide médecin sur les schizophrénies, 2007.
Cognitive abnormalities and schizophrenic symptoms, Psychological Medicine, vol.22, issue.4, pp.839-842, 1992. ,
The development of a cognitive model of schizophrenia: placing it in context, Neuroscience and Biobehavioral reviews, vol.29, issue.6, pp.977-988, 2005. ,
Self-disorders and schizophrenia: a phenomenological reappraisal of poor insight and noncompliance, Schizophrenia Bulletin, vol.40, issue.3, 2014. ,
,
, Nonadherence to medication four years after a first-episode of psychosis and associated risk factors, Psychiatric Services, issue.2, pp.189-192, 2010.
,
, Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years, Schizophrenia Research, vol.141, issue.2-3, 2012.
The concept of basic symptoms in schizophrenic and schizoaffective psychoses, Recenti Progressi in Medicina, vol.80, issue.12, pp.646-652, 1989. ,
Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis, Schizophrenia Research, vol.148, issue.1-3, pp.175-180, 2013. ,
Is schizophrenia universal?, Acta Psychiatrica Scandinavica, vol.344, pp.65-70, 1988. ,
,
, Schizophrenia: manifestations, incidence and course in different cultures. A world health organisation ten-country study, Psychological Medicine, vol.20, pp.1-97, 1992.
The Northwick Park Study of first-episodes of schizophrenia. I. Presentation of the illness and problems relating to admission, The British Journal of Psychiatry: The Journal of Mental Science, 1986. ,
Child development risk factors for adult schizophrenia in the british 1946 birth cohort, Lancet, vol.344, issue.8934, pp.1398-1402, 1994. ,
Polyunsaturated fatty acid supplementation for schizophrenia, Cochrane Database of Systematic Reviews, vol.3, issue.3, 2006. ,
EUFEST study groupe. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial, Lancet, vol.371, pp.1085-1097, 2008. ,
The neurobiology of disturbances of the self: autonoetic agnosia in schizophrenia, Insight and psychosis, pp.142-173, 1998. ,
Source monitoring deficits in patients with schizophrenia; a multinomial modeling analysis, psychological Medicine, vol.29, pp.903-914, 1999. ,
The problem of detecting changes in the incidence of schizophrenia, The British Journal of Psychiatry: The Journal of Mental Science, vol.162, pp.212-218, 1993. ,
Olfactory identification in young relatives at risk for schizophrenia, Acta Neuropsychiatrica, vol.21, issue.3, 2009. ,
,
, Psychosis-like
Diagnosing schizophrenia in the initial prodromal phase, Archives of General Psychiatry, 2001. ,
Prediction and prevention of schizophrenia: what has been achieved and where to go next?, World Psychiatry, vol.10, issue.3, pp.165-174, 2011. ,
Depression in first-episode schizophrenia, The American Journal of Psychiatry, vol.150, issue.11, 1993. ,
,
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition, Archives of general Psychiatry, vol.66, issue.7, 2009. ,
Early recognition and disease prediction in the at-risk mental state for psychosis using neurocognitive pattern classification, Schizophrenia Bulletin, 2011. ,
Validation of the french version of CAARMS in a psychiatric outpatient clinic for emerging psychological disorders (PREPP Programme), Schizophrenia Bulletin, vol.86, p.80, 2006. ,
Évaluation des états mentaux à risque de transition psychotique: validation de la version française de la CAARMS, L'Encéphale, vol.40, 2014. ,
Des prodromes à la notion de prévention. Association Congrès de Psychiatrie et de Neurologie de Langue Française (CPNLF), 2015. ,
Pharmacotherapy of first-episode psychosis, Expert Opinion on Pharmacotherapy, vol.4, issue.5, pp.717-750, 2003. ,
First-episode schizophrenia: I. Early course parameters, Schizophrenia Bulletin, vol.22, issue.2, pp.241-256, 1996. ,
,
, Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations, Biological Psychiatry, issue.12, pp.1008-1011, 2002.
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches, Biological Psychiatry, vol.50, pp.884-897, 2001. ,
,
, Duration of untreated psychosis and outcome in first-episode schizophrenia, The American Journal of Psychiatry, vol.149, issue.9, pp.1183-1188, 1992.
The self and schizophrenia: some open issues, World Psychiatry, 2012. ,
,
Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study, Psychological Medicine, vol.36, issue.5, pp.649-658, 2006. ,
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review, Archives of General Psychiatry, vol.62, issue.9, pp.975-983, 2005. ,
Early intervention for psychosis, Cochrane Database Systematic Reviews, vol.15, issue.6, 2011. ,
Self minimal et schizophrénie, 2016. ,
Methodological aspects of onset assessment in schizophrenia ,
, Schizophrenia Research, vol.15, pp.265-276, 1995.
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?, Biological Psychiatry, vol.46, issue.7, pp.899-907, 1999. ,
Les prémices de la schizophrénie, Les troubles schizophréniques, 2000. ,
,
,
,
double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis, American Journal of Psychiatry, vol.163, issue.5, pp.790-799, 2006. ,
A treatment-relevant classification of psychotic disorders, Australian and New Zealand Journal of Psychiatry, vol.29, issue.4, pp.555-558, 1995. ,
EPPIC: an evolving system of early detection and optimal management, Schizophrenia Bulletin, vol.22, pp.305-326, 1996. ,
,
, The « close-in » or ultra high risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder, Schizophrenia Bulletin, vol.29, issue.4, pp.771-790, 2003.
Scizophrenia: a concise overview of incidence, prevalence, and mortality, Epidemiologic Reviews, vol.30, pp.67-76, 2008. ,
,
Familiarity of novel factorial dimensions of schizophrenia, Archives of General Psychiatry, vol.66, issue.6, pp.591-600, 2009. ,
,
Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis, Archives of General Psychiatry, vol.65, issue.6, pp.634-640, 2008. ,
Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, inter rater reliability, and training to reliability, Schizophrenia Bulletin, vol.29, issue.4, pp.703-715, 2003. ,
The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior, Schizophrenia Bulletin, vol.26, pp.217-249, 2000. ,
Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis « prodromal » population, Schizophrenia Bulletin, vol.38, pp.1277-1287, 2012. ,
Not all first-episode psychosis is the same: preliminary evidence of greater basic self-disturbance in schizophrenia spectrum cases, Early Intervention In Psychiatry, issue.7, pp.200-204, 2013. ,
What are the neurocognitive correlates of basic self-disturbance in schizophrenia?: Integrating phenomenology and neurocognitions. Part 1 (Source monitoring deficits), Schizophrenia Research, 2014. ,
What are the neurocognitive correlates of basic self-disturbance in schizophrenia?: Integrating phenomenology and neurocognitions. Part 2 (Aberrant salience), Schizophrenia Research, p.152, 2014. ,
,
, Temporal persistence of anomalous self-experience: a 5 years follow-up
, Schizophrenia Research, vol.179, pp.36-40, 2017.
Self-disorders and the schizophrenia spectrum: a study of 100 first hospital admissions, Schizophrenia bulletin, vol.40, pp.1300-1307, 2014. ,
Duration of untreated psychosis ans cognitive functioning in first-episode patients, The British Journal of Psychiatry: The Journal of Mental Science, vol.179, pp.340-345, 2001. ,
How can the brain's resting state activity generate hallucinations? ,
, A « resting state hypothesis » of auditory verbal hallucinations, Schizophrenia Research, vol.127, issue.1-3, pp.202-214, 2011.
Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?, Current Drug Safety, vol.4, pp.84-93, 2009. ,
Self and schizophrenia: A phenomenological perspective, pp.127-141, 2003. ,
Autism in schizophrenia revisited, Comprehensive Psychiatry, vol.32, pp.1-15, 1991. ,
Phenomenology of anomalous self-experience in early schizophrenia, Comprehensive Psychiatry, vol.44, pp.121-155, 2003. ,
Anomalies of subjective experience in schizophrenia and psychotic bipolar illness, Acta Psychiatrica Scandinavica, vol.108, pp.126-159, 2003. ,
Self-experience in the prodromal phases of schizophrenia: A pilot study of first admissions, Psychiatry and Brain Research, vol.6, pp.107-123, 1998. ,
Psychiatric Diagnosis and Classification. World Psychiatric Association's series on Evidence and Experience in Psychiatry, pp.137-162, 2002. ,
,
, EASE: Examination of Anomalous Self-Experience, Psychopathology, vol.38, issue.5, 2005.
Selfexperience in the early phases of schizophrenia: 5-year follow-up of the Copenhagen prodromal study, Research Report. World Psychiatry, vol.10, pp.200-2004, 2011. ,
Adjunctive psychosocial therapies for the treatment of schizophrenia, Schizophrenia Research, vol.100, pp.108-119, 2008. ,
Duration of untreated psychosis as predictor of long-term outcome in first-episode schizophrenia: systematic review and meta-analysis, The British Journal of Psychiatry: The Journal of Mental Science, vol.205, issue.2, pp.88-94, 2014. ,
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis, The American Journal of Psychiatry, vol.162, issue.10, pp.1785-1804, 2005. ,
,
, Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities, The British Journal of Psychiatry, vol.187, issue.48, pp.33-44, 2005.
New insights into corollary discharges mediated by identified natural pathways, Trends in Neurosciences, vol.30, issue.1, pp.14-21, 2007. ,
The silent side of the spectrum: schizotypy and the schizotaxic self, Schizophrenia Bulletin, vol.37, pp.1017-1026, 2011. ,
Looking at the schizophrenia spectrum through the prism of self-disorders: an empirical study, Schizophrenia Bulletin, vol.37, pp.344-351, 2011. ,
Reliability and validity of methods for measuring the duration of untreated psychosis: a quantitative review and meta-analysis ,
, Schizophrenia Research, vol.160, pp.20-26, 2014.
,
The Basel Early-detection-of-Psychosis-Study-Design (FEPSY) and preliminary results, Acta Psychiatrica Scandinavica, vol.115, issue.2, pp.114-125, 2007. ,
,
Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up, Biological Psychiatry, vol.66, issue.11, pp.1023-1030, 2009. ,
,
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European Prediction of Psychosis Study, Archives of General Psychiatry, vol.67, issue.3, pp.241-251, 2010. ,
,
, Well-being among persons at risk of psychosis: the role of self-labeling, shame, and stigma stress, Psychiatric Services, vol.65, issue.4, pp.483-489, 2014.
Relationship between mental disorders in childhood and adulthood, Acta Psychiatrica Scandinavica, vol.91, issue.2, pp.73-85, 1995. ,
A systematic review of the prevalence of schizophrenia, Plos Medicine, vol.2, 2005. ,
,
,
, Axis I diagnoses and transition to psychosis in clinical high risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries, Schizophrenia Research, vol.138, issue.2-3, pp.192-197, 2012.
Madness and modernisme: insanity in the light of modern art, literature, and thought, 1992. ,
Self, consciousness, and schizophrenia, Schizophrenia Bulletin, vol.29, pp.427-444, 2003. ,
Explaining schizophrenia: the relevance of phenomenology, pp.63-96, 2007. ,
, Imaging Patients
Polyunsaturated fatty acids in emerging psychosis: a safer alternative, Early Intervention in Psychiatry, vol.8, issue.n°3, pp.199-208, 2014. ,
,
EPA guidance on the early intervention in clinical high risk states of psychoses, European Psychiatry, Special Issue: EPA Guidance Papers, vol.30, issue.3, pp.388-404, 2015. ,
The initial prodrome in schizophrenia: different duration, different underlying deficits?, Comprehensive Psychiatry, vol.48, issue.5, pp.479-488, 2007. ,
Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms ,
EPA guidance on early detection of clinical high risk states of psychoses, European Psychiatry, Special Issue: EPA Guidance Papers, vol.30, issue.3, pp.405-416, 2015. ,
North American Prodrome Longitudinal Study (NAPLS) Group. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis, Archives of General Psychiatry, issue.6, pp.578-588, 2010. ,
Neurocognitive predictors of source monitoring in schizophrenia, Psychiatry Research, vol.200, issue.2-3, pp.173-176, 2012. ,
The evaluation and treatment of first-episode psychosis, Schizophrenia Bulletin, vol.23, issue.4, pp.653-661, 1997. ,
Durée de la psychose non traitée: état des lieux et analyse critique ,
Embodiment and schizophrenia, World Psychiatry, vol.8, pp.56-59, 2009. ,
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring, Schizophrenia Bulletin, vol.35, issue.3, 2009. ,
Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia, Neuroscience, vol.137, issue.3, pp.807-819, 2006. ,
Chronology of comorbid and principal syndromes in first-episode psychosis, Comprehensive Psychiatry, vol.36, issue.2, pp.106-112, 1995. ,
The self and the SESMET, pp.483-518, 1999. ,
,
« just the facts » what we know en 2008. 2. Epidemiology and etiology, Schizophrenia Research, 2008. ,
,
Clinical features and conceptualisation, just the facts, vol.4, pp.1-3, 2009. ,
A neural model of the loss of self in schizophrenia, Schizophrenia Bulletin, vol.37, issue.6, 2011. ,
Catatonia in psychiatric classifications: a home of its own, The American Journal of Psychiatry, vol.160, issue.7, pp.1233-1241, 2003. ,
Predictive validity of clinical variables in the at risk for psychosis population : international comparison with results from the North American Prodrome Longitudinal Study, Schizophrenia Research, vol.126, pp.1-3, 2011. ,
Psychological interventions for psychosis: a meta-analysis of comparative outcome studies, American Journal of Psychiatry, vol.171, issue.5, pp.523-538, 2014. ,
,
,
, Auditory ERP components before and after transition to a first psychotic episode, Biological Psychology, vol.87, issue.3, 2011.
The relation of antipsychotic and antidepressant medication with baseline symptoms and symptoms progression: a naturalistic study of the North American Prodrome Longitudinal Sample, Schizophrenia Research, vol.115, issue.1, pp.50-57, 2009. ,
,
,
Hyperactivity and hyperconnectivity of the default network in schizophrenia and first-degree relatives of person with schizophrenia, Proceedings of the National Academy of Sciences of the USA, vol.106, issue.4, pp.1279-1284, 2009. ,
,
,
, Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia, Psychological Medicine, issue.5, p.41, 2011.
,
Predictors of outcome in first-episode schizophrenia over the first 4 years of illness, Psychological Medicine, vol.38, issue.8, pp.1141-1146, 2008. ,
Motor agency: a new and highly sensitive measure to reveal agency disturbances in early psychosis, PLoS One, vol.7, issue.2, p.30449, 2012. ,
Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study, British Journal of Psychiatry Supplement, 2007. ,
Is schizophrenia on the decline in Canada?, Canadian Journal of Psychiatry, vol.46, issue.1, pp.61-67, 2001. ,
First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment, The British Journal of Psychiatry, Supplement, issue.33, pp.77-83, 1998. ,
The initial prodrome in psychosis: descriptive and qualitative aspects, The Australian and New Zealand Journal of Psychiatry, vol.30, 1996. ,
The prodromal phase of first-episode psychosis: past and current conceptualisations, Schizophrenia Bulletin, vol.22, pp.353-370, 1996. ,
,
, Monitoring and care of young people at incipient risk of psychosis, Schizophrenia Bulletin, vol.22, issue.2, pp.283-303, 1996.
Psychosis prediction: 12-month follow-up of highrisk (« prodromal ») group, Schizophrenia Research, vol.60, pp.21-32, 2003. ,
Risk factors for psychosis in an ultrahigh-risk group: psychopathology and clinical features, Schizophrenia Research, vol.67, issue.2-3, 2004. ,
,
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States, The Australian and New Zealand Journal of Psychiatry, vol.39, pp.964-971, 2005. ,
Prediction of the psychosis: setting the stage, British Journal of Psychiatry Supplement, vol.51, pp.1-8, 2007. ,
Efficacy and safety of individual second-generation vs first-generation antipsychotics in firstepisode psychosis: a systematic review and meta-analysis, The International Journal of Neuropsychopharmacology, p.2013 ,
, Sous-type 5 : rituels/compulsions
, Perceptualisation du discours intérieur, ou de la pensée
, Sous-type 1 : perceptualisation interne
, Sous-type 2 : équivalent d'une perceptualisation
, Sous-type 3 : perceptualisation interne avec symptôme de premier rang
, Sous-type 1 : perturbation de l'expérience subjective du temps 1.14.2 Sous-type 2 : perturbation du temps existentiel
, Sous-type 2 : distance expérientielle/phénoménologique
, Sous-type 3 : spatialisation du soi
, Dépersonnalisation psychique
, Sous-type 1 : dépersonnalisation mélancoliforme
, Sous-type 2 : dépersonnalisation non spécifiée
, Sous-type 1 : déréalisation fluide, globale
, Sous-type 2 : déréalisation intrusive
,
, Dissociation du « Je
, Sous-type, vol.1, p.suspectée
, Sous-type 2 : expérience 'comme si
, Sous-type 3 : expérience spatialisée
, Sous-type 4 : élaboration délirante
, Dépersonnalisation dissociative
, Sous-type 1 : phénomène imaginatif 'comme si
, Sous-type 2 : hallucination visuelle dissociative
, Sous-type 1 : attaque de panique avec symptomatologie du système nerveux autonome 2.13.2 Sous-type 2 : anxiété psychique
, Sous-type 5 : angoisse diffuse, envahissante, flottante
, Sous-type 3 : autres phénomènes
, Dépersonnalisation somatique
, Sous-type 3 : blocage moteur
, Sous-type 4 : Sentiment d'une parésie motrice
, Sous-type 5 : Perte des automatismes moteurs
, Sous-type, vol.1
, Sous-type 2 : sentiment d'une disparition, d'une annihilation de soi
, Extraordinaires puissances créatrices, intuition extraordinaire
, Sentiments 'comme si' le monde ressenti n'était pas réel
, Idées magiques liées au mode d'expérience du sujet
, Changement existentiel ou intellectuel
, Grandeur solipsiste 186
Psychiatric Association EPOS: European Prevention of Psychosis Study GAF: Global Assessment of Functioning HAQ-IIp: Revised Helping Alliance Questionnaire; questionnaire de l'alliance aidante HAV: Hallucinations acoustico-verbales NAPLS: North American Prodrome Longitudinal Study OASIS: Outreach And Support in South London OPCRIT: Operational Criteria Checklist fo Psychotic illness and affective illness PACE: Personal Assessment and Crisis Evaluation PANSS: Positive And Negative Syndrome Scale PEP: Premier Épisode Psychotique PRIME: Prevention through Risk Identification Management and Education project 187 SCID, Antipsychotique APS: Attenuated Positif Symptoms ARMS: At Risk Mental State AUDIT: Alcohol Use Disorders Test BLIPS: Brief Limited Intermittent Psychotic Symptoms BPRS: Brief Psychiatric Rating Scale BS: Basic Symptoms BSABS: Bonn Scale for the Assessment of Basic Symptoms BSIP: Basel Screening Instrument for Psychosis CAARMS: Comprehensive Assessment of At-Risk Mental States CASH: Comprehensive Assessment of Symptoms and History CHR: Clinical High Risk CIP: Centre d'Intervention Précoce CMP: Centre Médico Psychologique CODGIS: Cognitive Disturbances Scale CPJ: Centre Psychothérapique de Jour CTQ: Childhood Trauma Questionnaire DEP: Deuxième Épisode Psychotique DUDIT: Drug Use Disorders Test EFSP: Échelle de Fonctionnement Social et Professionnel EM: Entretien Motivationnel EPA: European ,